anti-human G-CSF monoclonal antibody (CSL)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-human G-CSF monoclonal antibody (CSL)
Drug Alias Nameanti-human G-CSF monoclonal antibody (MuriGen/CSL)anti-human G-CSF monoclonal antibody (MuriGen/Zenyth)mAb hG-CSF
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionColony stimulating factor 3 receptor inhibitors
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMuriGen Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCSL Innovation PTY LtdMuriGen TherapeuticsCsl Ltd
Active IndicationsN/A
Inactive IndicationsArthritis

Other Information

ATC CodeN/A
Related LinksN/A